Olmesartan medoxomil impurity (N1,N2-5-methyl-1,3-dioxol-2-one)

SL-3675

Olmesartan medoxomil impurity (N1,N2-5-methyl-1,3-dioxol-2-one), >98%

CAS No. : [1392475-91-0]

Related CAS No. : <span style="caret-color: rgb(85, 85, 85); color: rgb(85, 85, 85); font-family: Arial; font-size: 14px; white-space: pre-wrap; background-color: rgb(255, 255, 255);">[1392475-91-0] &amp; [1878117-43-1]of both products.</span>

Synonyms : Olmesartan bis-medoxomil (1H-1-Medoxomil + 2H-2-Medoxomil mixture)

IUPAC Name : (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-1-((2'-(1-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-propyl-1H-imidazole-5-carboxylate--(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-1-((2'-(2-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-propyl-1H-imidazole-5-carboxylate (1/1)

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Olmesartan bis-medoxomil is an impurity of Olmesartan medoxomil (N1,N2-5-methyl-1,3-dioxol-2-one), which is a selective angiotensin II type 1 (AT(1)) receptor antagonist, used in the treatment of high blood pressure.

References : Kurikawa N. et al.: Br. J. Pharmacol.,139(6), 1085-1094, 2003; Koike H. et al.: J. Hypertens Suppl., 9(1), S3-14, 2001; Nagib M. M. et al.: Toxicol Appl Pharmacol., 271(1), 106-113, 2013; Nakamoto T. et al.: Eur. J. Pharmacol., 528(1-3), 43-51, 2005.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.